Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Blood Collection

Research Leaders

7 sponsors active, led by Institut Pasteur

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Suspended1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT05153018Not ApplicableCompleted

Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu

NCT05218304Not ApplicableSuspended

Baromètre Santé Adulte 2021-2022

Showing all 2 trials

Research Network

Common Treatments

  • Blood Collection1
  • Blood Sample1

Active Sponsors

  • Institut Pasteur2
  • Ministry of Health, Vanuatu1
  • Agence Sanitaire et Sociale de Nouvelle Calédonie1
  • Pacific Community1
  • Vanuatu National Hospital1

Top Investigators

Related Conditions

  • Zika2
  • Chikungunya2
  • Renal Failure1
  • Sarscov Infection1
  • Arbovirus Disease1

Activity Timeline